Screener
AngioDynamics ANGO Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Goodwill impairment | — | — | 159,476 |
| Change in fair value of contingent consideration | — | 272 | 432 |
| Acquisition, restructuring and other items, net | 17,598 | 15,620 | 53,182 |
| Total operating expenses | 214,819 | 197,659 | 401,632 |
| Gain on sale of assets | — | — | 54,499 |
| Operating loss | (39,927) | (39,954) | (192,435) |
| Other expenses | |||
| Interest income (expense), net | (299) | 978 | 1,614 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's total operating expenses?
- AngioDynamics (ANGO) reported total operating expenses of $56.97M in Q1 2026.
- How has AngioDynamics's total operating expenses changed year-over-year?
- AngioDynamics's total operating expenses increased by 18.7% year-over-year, from $48.01M to $56.97M.
- What is the long-term trend for AngioDynamics's total operating expenses?
- Over 4 years (2022 to 2026), AngioDynamics's total operating expenses has grown at a 2.6% compound annual growth rate (CAGR), from $194.2M to $214.82M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about AngioDynamics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude